Strains of Escherichia coli isolated from the urine of children with pyelonephritis (n = 18) or asymptomatic bacteriuria (ABU) (n = 20) were serotyped and compared with respect to opsonic requirements, sensitivity to serum, amount of chemiluminescence produced by normal neutrophils during phagocytosis of the various strains, and amount of capsular antigen. Strains isolated from cases of ABU more often had the capacity to activate the alternative complement pathway than had strains causing pyelonephritis. The ABU strains were also better opsonized in fresh human serum and were more often serum sensitive than the pyelonephritic strains. There were individual variations in neutrophil chemiluminescence during phagocytosis of the various strains, but the two groups of strains did not differ significantly. The strains from pyelonephritis cases produced a greater amount of capsular antigens than the ABU strains. There was no correlation between presence of a particular 0 or K antigen and capacity to activate the alternative complement pathway. The observed differences between strains isolated from patients with ABU and those isolated from patients with pyelonephritis may be relevant for further studies on differences in bacterial virulence or host defense factors.
Strains of Escherichia coli isolated from the urine of children with pyelonephritis (n = 18) or asymptomatic bacteriuria (ABU) (n = 20) were serotyped and compared with respect to opsonic requirements, sensitivity to serum, amount of chemiluminescence produced by normal neutrophils during phagocytosis of the various strains, and amount of capsular antigen. Strains isolated from cases of ABU more often had the capacity to activate the alternative complement pathway than had strains causing pyelonephritis. The ABU strains were also better opsonized in fresh human serum and were more often serum sensitive than the pyelonephritic strains. There were individual variations in neutrophil chemiluminescence during phagocytosis of the various strains, but the two groups of strains did not differ significantly. The strains from pyelonephritis cases produced a greater amount of capsular antigens than the ABU strains. There was no correlation between presence of a particular 0 or K antigen and capacity to activate the alternative complement pathway. The observed differences between strains isolated from patients with ABU and those isolated from patients with pyelonephritis may be relevant for further studies on differences in bacterial virulence or host defense factors.
Urinary tract infection is a considerable problem and is most often caused by Escherichia coli (1). To better understand variables relevant for prevention and treatment of urinary tract infection, better knowledge about host defense factors and bacterial virulence is needed. In a previous study, we found that K antigens, especially K1, are more common and occur in greater amounts in strains causing acute pyelonephritis than in strains causing acute cystitis or asymptomatic bacteriuria (ABU) (6, 8) . In another recent study we reported that individual E. coli strains isolated from newborn infants vary in opsonic requirements, i.e., with regard to capacity to activate the alternative complement pathway (2) . Strains with the capacity to activate the alternative pathway were more efficiently opsonized in fresh pooled human serum than were strains lacking this capacity. Opsonization is critical for phagocytosis of E. coli and thus for an efficient host defense against invading microorganisms.
The aim of the present investigation was to compare opsonization and phagocytosis of strains isolated from the urine of patients with acute pyelonephritis and strains isolated from cases of ABU, to reach a better understanding of mechanisms critical for host defense in E. coli infections.
(This work was presented in part at a meeting of the European Society for Pediatric Research, Turku, Finland, 25-29 June 1978.) MATERIALS AND METHODS Bacterial strains. E. coli strains were isolated from the urine of children treated for urinary tract infection at Childrens Hospital, Gothenburg, Sweden. The criteria for pyelonephritis were as described elsewhere (5); i.e., fever, >38.50C; loin or high abdominal pain; renal concentrating capacity, <815 mosmol/liter; erythrocyte sedimentation rate, >25 mm/h; and C-reactive protein, >10 mg/liter. ABU strains were obtained from healthy school children in a screening program (5) . The strains were grown on Drigalski agar plates (9). They were 0 grouped according to Lidin-Janson et al. (10) and K typed according to Kaijser (7) . The form variation of the Kl antigen (Kl-/K1+), as described by 0rskov et al., was also considered (12) .
All but one of the Kl strains were found to be the K1-variant. Extraction and quantitation of K antigen from the bacteria were performed in Veronal buffer extract from the bacterial cells, as earlier described using crossed immunoelectrophoresis (6 Opsonic activity. Two E. coli strains from patients with ABU were opsonized in Mg-EGTA-chelated serum significantly more often than strains from patients with pyelonephritis (P < 0.001; chi square, 13.49; 1 df) ( Table 2) . The difference between pyelonephritis and ABU strains was not related to the presence of a particular K or 0 antigen. The ABU strains were more efficiently opsonized in PHS than the pyelonephritis strains (P < 0.01; chi square, 9.02; 1 dfl). Table 2 shows results obtained when the opsonic activity in 8% PHS was tested. The results were similar when 2% PHS was used. Sensitivity to serum. The ABU strains were significantly more often sensitive to the bactericidal activity of normal serum than the pyelonephritis strains (Table 2 ) (P< 0.001; chi square, 15.63; 1 df).
Chemiluminescence. Neutrophil chemiluminescence during phagocytosis of E. coli varied with the individual strains tested, but there was no significant difference between pyelonephritis and ABU strains. The chemiluminescence during phagocytosis of the various E. coli strains was 4 to 23% of the chemiluminescence occurring during phagocytosis of zymosan, which was used as reference when results of different experiments were compared. The average chemiluminescence during phagocytosis of pyelonephritis strains was 12.7 ± 4.6% (standard deviation) of the simultaneously tested zymosan controls and 11.8 ± 4.7% during phagocytosis of ABU strains.
DISCUSSION
The course of a urinary tract infection is influenced by the relationship between the host and the bacteria; i.e., host immunity and anatomy as well as bacterial virulence factors are significant. Phagocytosis and killing of invading bacteria presumably play an important role in this defense and may be critical for the course of the infection. Previous studies have revealed that E. coli strains isolated from patients with acute pyelonephritis are significantly less sensitive to the bactericidal activity of serum than strains isolated from ABU (11) . Also, in the pyelonephritis strains K antigen was present more often and in greater amounts than in the ABU strains (Table 1) .
Recently we found that E. coli strains vary in capacity to activate the alternative complement pathway (2) . In the present investigation of 38 (Table 2) . However, the pyelonephritis strains contained more capsular antigen than the ABU strains. Our previous studies of bacterial strains isolated from the stools of healthy newborn infants or from blood or cerebrospinal fluid of septic neonates after retyping (2, 3) showed a significant correlation between the presence of Kl antigen on the bacteria and opsonic requirements. The Kl strains, however, except for one, were isolated from sick infants and most of the non-Kl strains were stool isolates.
Thus, the reported difference in opsonic requirements may be related to other factors in addition to Kl antigen. Even if the K antigen has been shown to be a virulence factor (14, 15) , there are other bacterial components which might contribute to virulence or are present together with virulence factors. So far they cannot all be defined, but their activity might be indirectly measured, for example, by testing the capacity of activating the classical or alternate pathway.
